Franch-Nadal J.,Institute Catala Of La Salut |
Franch-Nadal J.,Institute Universitari Of Investigacio En Atencio Primaria Jordi Gol |
Mata-Cases M.,Institute Universitari Of Investigacio En Atencio Primaria Jordi Gol |
Mata-Cases M.,Institute Catala Of La Salut |
And 7 more authors.
International Journal of Endocrinology | Year: 2014
The objective of this cross-sectional study was to assess differences in the control and treatment of modifiable cardiovascular risk factors (CVRF: HbA1c, blood pressure [BP], LDL-cholesterol, body mass index, and smoking habit) according to gender and the presence of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) in Catalonia, Spain. The study included available data from electronic medical records for a total of 286,791 patients. After controlling for sex, age, diabetes duration, and treatment received, both men and women with prior CVD had worse cardiometabolic control than patients without previous CVD; women with prior CVD had worse overall control of CVRFs than men except for smoking; and women without prior CVD were only better than men at controlling smoking and BP, with no significant differences in glycemic control. Finally, although the proportion of women treated with lipid-lowering medications was similar to (with prior CVD) or even higher (without CVD) than men, LDL-cholesterol levels were remarkably uncontrolled in both women with and women without CVD. The results stress the need to implement measures to better prevent and treat CVRF in the subgroup of diabetic women, specifically with more intensive statin treatment in those with CVD. © 2014 Josep Franch-Nadal et al. Source